Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.

Human parainfluenza viruses (HPIVs) are a leading cause of acute respiratory infection hospitalization in children, yet little is known about how dose, strain, tissue tropism, and individual heterogeneity affects the processes driving growth and clearance kinetics. Longitudinal measurements are poss...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lubna Pinky, Crystal W Burke, Charles J Russell, Amber M Smith
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/d3c9ec477df046dcad760f539c2dad11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d3c9ec477df046dcad760f539c2dad11
record_format dspace
spelling oai:doaj.org-article:d3c9ec477df046dcad760f539c2dad112021-12-02T19:58:05ZQuantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.1553-734X1553-735810.1371/journal.pcbi.1009299https://doaj.org/article/d3c9ec477df046dcad760f539c2dad112021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009299https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358Human parainfluenza viruses (HPIVs) are a leading cause of acute respiratory infection hospitalization in children, yet little is known about how dose, strain, tissue tropism, and individual heterogeneity affects the processes driving growth and clearance kinetics. Longitudinal measurements are possible by using reporter Sendai viruses, the murine counterpart of HPIV 1, that express luciferase, where the insertion location yields a wild-type (rSeV-luc(M-F*)) or attenuated (rSeV-luc(P-M)) phenotype. Bioluminescence from individual animals suggests that there is a rapid increase in expression followed by a peak, biphasic clearance, and resolution. However, these kinetics vary between individuals and with dose, strain, and whether the infection was initiated in the upper and/or lower respiratory tract. To quantify the differences, we translated the bioluminescence measurements from the nasopharynx, trachea, and lung into viral loads and used a mathematical model together a nonlinear mixed effects approach to define the mechanisms distinguishing each scenario. The results confirmed a higher rate of virus production with the rSeV-luc(M-F*) virus compared to its attenuated counterpart, and suggested that low doses result in disproportionately fewer infected cells. The analyses indicated faster infectivity and infected cell clearance rates in the lung and that higher viral doses, and concomitantly higher infected cell numbers, resulted in more rapid clearance. This parameter was also highly variable amongst individuals, which was particularly evident during infection in the lung. These critical differences provide important insight into distinct HPIV dynamics, and show how bioluminescence data can be combined with quantitative analyses to dissect host-, virus-, and dose-dependent effects.Lubna PinkyCrystal W BurkeCharles J RussellAmber M SmithPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 8, p e1009299 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Lubna Pinky
Crystal W Burke
Charles J Russell
Amber M Smith
Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
description Human parainfluenza viruses (HPIVs) are a leading cause of acute respiratory infection hospitalization in children, yet little is known about how dose, strain, tissue tropism, and individual heterogeneity affects the processes driving growth and clearance kinetics. Longitudinal measurements are possible by using reporter Sendai viruses, the murine counterpart of HPIV 1, that express luciferase, where the insertion location yields a wild-type (rSeV-luc(M-F*)) or attenuated (rSeV-luc(P-M)) phenotype. Bioluminescence from individual animals suggests that there is a rapid increase in expression followed by a peak, biphasic clearance, and resolution. However, these kinetics vary between individuals and with dose, strain, and whether the infection was initiated in the upper and/or lower respiratory tract. To quantify the differences, we translated the bioluminescence measurements from the nasopharynx, trachea, and lung into viral loads and used a mathematical model together a nonlinear mixed effects approach to define the mechanisms distinguishing each scenario. The results confirmed a higher rate of virus production with the rSeV-luc(M-F*) virus compared to its attenuated counterpart, and suggested that low doses result in disproportionately fewer infected cells. The analyses indicated faster infectivity and infected cell clearance rates in the lung and that higher viral doses, and concomitantly higher infected cell numbers, resulted in more rapid clearance. This parameter was also highly variable amongst individuals, which was particularly evident during infection in the lung. These critical differences provide important insight into distinct HPIV dynamics, and show how bioluminescence data can be combined with quantitative analyses to dissect host-, virus-, and dose-dependent effects.
format article
author Lubna Pinky
Crystal W Burke
Charles J Russell
Amber M Smith
author_facet Lubna Pinky
Crystal W Burke
Charles J Russell
Amber M Smith
author_sort Lubna Pinky
title Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
title_short Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
title_full Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
title_fullStr Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
title_full_unstemmed Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
title_sort quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d3c9ec477df046dcad760f539c2dad11
work_keys_str_mv AT lubnapinky quantifyingdosestrainandtissuespecifickineticsofparainfluenzavirusinfection
AT crystalwburke quantifyingdosestrainandtissuespecifickineticsofparainfluenzavirusinfection
AT charlesjrussell quantifyingdosestrainandtissuespecifickineticsofparainfluenzavirusinfection
AT ambermsmith quantifyingdosestrainandtissuespecifickineticsofparainfluenzavirusinfection
_version_ 1718375807344181248